Signature »

Aeglea Biotherapeutics shares owned by Signature

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Signature from 13F filings

Historical chart of Signature investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Signature consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Signature

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.3k 70 32.76
2025-09-30 $1.2k 70 16.76
2025-06-30 $2.5k 165 14.97
2024-12-31 $1.6k 68 23.28

More positions owned by Signature

Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard Malvern Fds Core Bd Etf (VCRB)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr National Mun Etf (MUB)
Vanguard Index Fds Large Cap Etf (VV)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Signature

Top funds holding Aeglea Biotherapeutics

FMR
Vanguard Group
Fairmount Funds Management
BlackRock
VR Adviser
Rtw Investments
Tang Capital Management
Capital Research and Management Company - Division 3
State Street Corporation
Driehaus Capital Management
Commodore Capital
Geode Capital Management
Wellington Management Company
Braidwell
Paradigm Biocapital Advisors

View all funds holding Aeglea Biotherapeutics